데이터 상품 상세검색

[감염병연구]

간암 환자 의료 및 단백체 데이터

간암 환자 및 단백체 데이터

  • 등록일2023-11-20
  • 조회수189
  • 다운로드69
  • 카테고리감염병연구
  • 0

데이터 기본 이용료

  • 무료
상세정보
데이터등록일 데이터 수정일 데이터 이용기한 판매제공처
2023-11-20 2023-12-06 무기한 셀키
데이터 제공포맷 데이터 제공방식 데이터 파일용량 데이터 상품구분
csv/zip 다운로드 9.10 MB dataset

● 데이터 상품명 간암 환자 의료 및 단백체 데이터 ● 데이터 상품 부제 간암 특화 임상 및 단백체 데이터와 의료데이터 ● 데이터 상품 요약 미국 국립암연구소 (NCI)의 간암 의료 및 단백체 정성·정량 분석 결과 ● 데이터 상품 정보 ■ 상품 설명 및 특징 - 국내 최초·최대 암 관련 (관련 질병 포함) 당 단백질 질량분석 실험 데이터의 해석 및 당·단백질 리포지토리를 구축하고 정밀의료 연구기술에 발전시키고자 함 - 간암 환자 시료를 전처리하여 고분해능 질량분석기기를 통해 최적화된 분석을 진행하고 당사에서 자체 개발한 분석솔루션 SpAC9 Pipeline을 활용하여 데이터분석 등의 프로세스를 통하여 표준화 기준에 맞춰 최종 데이터를 가공, 생산함 - NCI 의 CPTAC에서 제공된 질량분석이 완료된 간암 RAW 데이터는 SpAC9 Pipeline을 활용하여 재분석하고 표준화 기준에 맞춰 데이터를 가공·생산함 ■ 기간 및 범위 - 2023년 9월 ~ 2023년 10월 ■ 컬럼(속성) 정보 - 집계시작년월 : 2023년 9월 - 집계시작년월 : 2023년 10월 ■ 약어/전문용어 설명 - NCI: National Cancer Institute - CPTAC: Clinical Proteome Tumor Analysis Consortium ■ 활용 예제 - 시스템 확대·발전 - 의료 및 단백체 빅데이터 고도화를 위한 유전단백체 변이 아틀라스 구축으로 시스템 확대 및 발전 - 인간의 유전단백체 변이 아틀라스를 구축하여 질병 별로 유전자 변이가 단백질의 변이를 일으키는 경우의 데이터베이스 구축하여 질병의 이해와 개인 맞춤형 신약 개발 및 진단 발굴 사업에 필요한 데이터를 제공

샘플정보
그룹명
결과파일명
결과ID
질량분석기기분석일자
생성일자
수정일자
ID
환자ID
샘플ID
암코드
분석정보
환자성별
환자나이
병리학유형
종양분화수준
간경변병력유무
간결정센티미터범위
종양수
종양센티미터크기
종양혈전여부
포르타간염림프절
종양캡슐화
간염병력유무
B형간염표면항원보유유무
B형간염코어항체보유유무
프로트롬빈함량
빌리루빈함량
알부민함량
알라닌아미노전이효소함량
감마글루타밀전이효소함량
알파태아단백질함량
유전자심볼
단백질심볼
단백질명
펩타이드명
펩타이드질량
펩타이드전하
펩타이드스캔1ID
펩타이드스캔2ID
펩타이드값
펩타이드함량
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F07.raw CPTAC_LIHC_Proteome 20171001 20230918 417848 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_000331.1(pre=K,post=-) FLGATETV 534 2 17775 17781 70 5458510000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F07.raw CPTAC_LIHC_Proteome 20171001 20230918 420411 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001340275.1(pre=R,post=G) GNPTVEVDLFTSK 933 2 18527 18539 114 35939000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 451522 125.HCC.3 126 LIHC 130C male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 XXX_NP_004827.4(pre=R,post=I) SIYGSNK 614 2 9369 9373 43 515886000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 451524 113.HCC.2 114 LIHC 128C male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 XXX_NP_004827.4(pre=R,post=I) SIYGSNK 614 2 9369 9373 43 515886000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 452108 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_060084.2(pre=K,post=F) AGASIVGVNCR 445 3 9705 9707 96 324245000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 452110 112.HCC.2 112 LIHC 127N male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_060084.2(pre=K,post=F) AGASIVGVNCR 445 3 9705 9707 96 324245000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 454908 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_000764.1(pre=M,post=L) KYPEIEEK 575 3 10841 10849 81 76355600
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F07.raw CPTAC_LIHC_Proteome 20171001 20230918 424331 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_066307.1(pre=R,post=S) GILCHYLEEGAQCPAPL 720 3 19519 19526 151 373685000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 454909 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_000764.1(pre=M,post=L) KYPEIEEK 575 3 10841 10849 81 76355600
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 458998 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_055557.2(pre=R,post=D) LELYSNR 562 2 12121 12136 73 2008240000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 458999 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_055557.2(pre=R,post=D) LELYSNR 562 2 12121 12136 73 2008240000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F07.raw CPTAC_LIHC_Proteome 20171001 20230918 427911 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001186220.1(pre=R,post=H) LSGDWNPL 566 2 20767 20770 85 1755300000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F07.raw CPTAC_LIHC_Proteome 20171001 20230918 429411 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001340275.1(pre=R,post=G) GNPTVEVDLFTSK 622 3 21231 21244 61 40193800
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F07.raw CPTAC_LIHC_Proteome 20171001 20230918 436061 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 XXX_NP_112589.1(pre=-,post=Q) SEVLPFH 529 2 23439 23452 38 11688600
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 452591 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 XXX_NP_001161212.1(pre=K,post=D) EKGLLCR 667 2 9833 9844 47 149100000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 454281 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001303886.1(pre=R,post=A) GMSEALK 597 2 10633 10636 105 4381390000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 455719 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_444267.1(pre=K,post=E) TVINDPSYK 748 2 11081 11085 131 12659600000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 456439 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 MSN NP_002435.1(pre=K,post=E) moesin GN=MSN YGDFNK 601 2 11369 11371 75 12474000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 457349 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_001284484.1(pre=K,post=Y) QTGYLTIGGQR 712 2 11641 11656 119 0
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 459903 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001159446.1(pre=K,post=I) AAVIVGC 460 2 12425 12438 67 281772000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 464620 112.HCC.2 112 LIHC 127N male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_001306115.1(pre=K,post=E) LVIDEPAK 672 2 13865 13867 115 10871000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 467360 112.HCC.2 112 LIHC 127N male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_004078.2(pre=R,post=S) ALHLLEEYR 458 3 14633 14637 82 1198660000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 468578 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001618.2(pre=R,post=N) QIGDALPVSCTISASR 953 2 14969 14979 144 225459000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 482948 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001313254.1(pre=K,post=Y) GCCFVTF 560 2 18905 18911 57 75446400
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 473949 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 XXX_NP_076917.1(pre=K,post=D) RTRLTYEMHRTISWYR 805 3 16409 16417 41 281099000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 486611 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001157844.1(pre=K,post=F) AICGLIDDYSMVR 581 3 20089 20104 59 23412700
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 505766 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 XXX_NP_954984.1(pre=K,post=T) SKWITVR 450 3 6946 6951 84 163868000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 488781 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001307341.1(pre=K,post=A) ALEMGVFG 527 2 20729 20736 72 278520000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 506226 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_000752.2(pre=K,post=M) NPHLALSR 380 3 7186 7189 67 8792670000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 492103 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001306125.1(pre=K,post=H) ALNSIIDVY 619 2 21833 21842 81 336487000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 493901 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 ESPL1 NP_036423.4(pre=E,post=P) separin GN=ESPL1 VCPTESK 640 2 22457 22469 52 1923730000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 495337 125.HCC.3 125 LIHC 130N male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_001243385.1(pre=R,post=A) AFADNPGPMVVF 747 2 22969 22973 55 63630200
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 508063 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001908.3(pre=K,post=G) HFILTHDPER 374 4 8338 8342 74 6466270000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 508064 113.HCC.2 114 LIHC 128C male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_001908.3(pre=K,post=G) HFILTHDPER 374 4 8338 8342 74 6466270000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 508069 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_001908.3(pre=K,post=G) HFILTHDPER 374 4 8338 8342 74 6466270000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 508113 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001908.3(pre=K,post=G) HFILTHDPER 747 2 8354 8362 124 865780000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 498827 125.HCC.3 125 LIHC 130N male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_036386.1(pre=R,post=D) MLSPFELVQFDMEAAEPVR 819 3 24281 24283 129 198948000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F08.raw CPTAC_LIHC_Proteome 20171001 20230918 499525 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_079019.3(pre=R,post=Q) TYWDFEFPQPY 861 2 24521 24533 62 3296030
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 508599 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 XXX_NP_066973.2(pre=-,post=T) LTNTPER 530 2 8562 8570 33 305833000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 503985 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_001350789.1(pre=K,post=R) TATAVAHCK 473 3 5346 5352 105 15982900000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 509557 125.HCC.3 125 LIHC 130N male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_001093251.1(pre=F,post=T) GAMVYSPR 555 2 9026 9030 93 1264250000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 504347 125.HCC.3 125 LIHC 130N male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_001116319.1(pre=K,post=D) YHNNCYK 486 3 5666 5671 62 144711000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 506751 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 XXX_NP_703191.1(pre=S,post=L) YLLLAARGRAAAGSRVDQK 619 4 7618 7633 54 17571000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 510106 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 XXX_NP_057191.2(pre=R,post=T) LQNQTGR 523 2 9250 9255 66 1408180000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 513931 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001349839.1(pre=-,post=V) MFDHPIPR 415 3 10658 10665 78 451359000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 515151 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_004402.1(pre=R,post=V) TPLSAAAHTHPVYCVN 656 3 11106 11111 156 848331000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 535460 112.HCC.2 112 LIHC 127N male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_003048.1(pre=K,post=T) GNWMAGY 514 2 17154 17163 57 159440000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 516406 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 UTRN NP_009055.2(pre=R,post=E) utrophin GN=UTRN EVPTTLK 623 2 11442 11453 113 1524810000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 517188 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 PPL NP_002696.3(pre=K,post=D) periplakin GN=PPL YGPDFK 593 2 11618 11625 59 488634000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 527401 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_000769.2(pre=R,post=V) VQLYDPDYMK 873 2 14802 14817 109 99891200
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 531451 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001350671.1(pre=R,post=L) IWTVDDYR 649 2 16098 16103 92 359757000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 538239 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_006200.3(pre=N,post=G) SMYDPVFDATFHLR 643 3 19474 19488 61 60042300
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 548221 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001307341.1(pre=Y,post=V) TFVGPPECVVEGALNAAR 706 3 20834 20848 101 2267040000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 549186 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001068.1(pre=K,post=M) NDLEDFFMK 809 2 21218 21228 117 220193000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 550493 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001527.3(pre=K,post=I) WLAPDGL 501 2 21666 21679 41 18254300
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 563116 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001244941.2(pre=R,post=E) GQGTGKPR 420 3 3535 3550 63 718772000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 552611 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 SON NP_620305.2(pre=R,post=A) protein SON isoform F GN=SON LSENAFDLEAMSMLNR 1036 2 22466 22476 152 41420100
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F09.raw CPTAC_LIHC_Proteome 20171001 20230918 552701 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 ACTB NP_001092.1(pre=R,post=G) actin, cytoplasmic 1 GN=ACTB CPEALFQPSFLGMESC 1059 2 22498 22507 66 74284300
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 576793 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 VIL1 NP_009058.2(pre=Y,post=Y) villin-1 GN=VIL1 QAVILDQK 687 2 12095 12105 104 1071510000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 621692 125.HCC.3 126 LIHC 130C male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_734466.1(pre=R,post=I) KGNYAER 433 3 4933 4948 47 175654000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 576841 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_002141.1(pre=K,post=K) MPINEPAPGK 505 3 12111 12119 95 118006000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 621695 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_734466.1(pre=R,post=I) KGNYAER 433 3 4933 4948 47 175654000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 621696 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_734466.1(pre=R,post=I) KGNYAER 433 3 4933 4948 47 175654000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 621702 125.HCC.3 126 LIHC 130C male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_734466.1(pre=R,post=I) KGNYAER 648 2 4949 4950 76 27599000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 623350 112.HCC.2 112 LIHC 127N male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_055557.2(pre=R,post=V) EDMEEDQEHTYR 604 3 6677 6683 124 1022910000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 625069 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_001295169.1(pre=K,post=A) SQAALQK 602 2 7797 7805 99 9233840000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 586131 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001309015.1(pre=K,post=V) WLNENAVEK 781 2 14975 14978 148 24832900000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 625133 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001295169.1(pre=K,post=A) SQAALQK 402 3 7829 7834 75 208309000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 590791 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001337004.1(pre=K,post=N) LNEVYEAVK 762 2 16415 16423 140 166520000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 591191 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NMI NP_004679.2(pre=K,post=K) N-myc-interactor GN=NMI GLIDEITK 450 3 16511 16522 86 20672000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 626882 125.HCC.3 126 LIHC 130C male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_000764.1(pre=R,post=F) KHFDYNDEK 628 3 8629 8641 132 2624710000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 626889 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_000764.1(pre=R,post=F) KHFDYNDEK 628 3 8629 8641 132 2624710000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 626890 112.HCC.2 112 LIHC 127N male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_000764.1(pre=R,post=F) KHFDYNDEK 628 3 8629 8641 132 2624710000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 593664 113.HCC.2 114 LIHC 128C male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_009051.1(pre=F,post=K) SLGSMVSEIPEK 434 4 17263 17265 90 394914000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 599241 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 XXX_NP_060609.2(pre=E,post=F) VAELATADLMQR 782 2 19023 19032 36 311196000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 599681 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_009051.1(pre=R,post=L) VTLGYTQGFFETEH 929 2 19135 19143 116 41939000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 600671 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001131026.1(pre=K,post=M) GIGIENIHYLNDGLWH 694 3 19471 19474 151 1413120000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 628949 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_001310011.1(pre=K,post=F) EVVGIAHK 656 2 9525 9535 122 1283420000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 602549 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_001309172.1(pre=G,post=I) AAGTVFTTVEDLGSK 652 3 19983 19997 74 8244510000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 607716 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_001074003.1(pre=R,post=R) TLSGEMDVWYNLEK 715 3 21519 21532 113 27814800
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 610383 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001071105.1(pre=R,post=W) DSAAAVVVYDITNVNSFQQTTK 708 4 22351 22363 102 889027000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 613146 127.HCC.3 127 LIHC 131 male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_002141.1(pre=C,post=N) SLEMIDHIVGNQPDQEMVSASEWYLK 870 4 23327 23331 149 45389400
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 614182 125.HCC.3 126 LIHC 130C male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_001527.3(pre=R,post=G) DLDFTIDLDFK 601 3 23663 23677 35 29224800
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 615198 123.HCC.3 123 LIHC 129N male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001311045.1(pre=R,post=R) VDGVYQVVEYSEISLATAQK 665 4 24015 24018 137 348029000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 615199 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_001311045.1(pre=R,post=R) VDGVYQVVEYSEISLATAQK 665 4 24015 24018 137 348029000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F10.raw CPTAC_LIHC_Proteome 20171001 20230918 617161 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_066307.1(pre=K,post=Y) ESSFDAVFLDPFDNCGLIVAK 935 3 24639 24643 175 181474000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 621085 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_001244941.2(pre=R,post=E) GQGTGKPR 630 2 3317 3321 64 31049800
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 621681 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 NP_734466.1(pre=R,post=I) KGNYAER 433 3 4933 4934 88 175654000000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 625063 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 NP_001295169.1(pre=K,post=A) SQAALQK 602 2 7797 7805 99 9233840000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 630922 125.HCC.3 126 LIHC 130C male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_009051.1(pre=N,post=A) DLLGHPMTR 424 3 10309 10321 72 98388800
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 630505 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 ACO1 NP_001265281.1(pre=R,post=L) cytoplasmic aconitate hydratase GN=ACO1 GTFANIR 504 2 10149 10152 103 12991700000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 630863 123.HCC.3 124 LIHC 129C male 79 HCC 3 0 0 1 16 0 0 1 1 1 0 11 17 35 22 67 38142 CAPN5 NP_004046.2(pre=R,post=Q) calpain-5 GN=CAPN5 LHGAWTLHEDPR 416 4 10277 10280 74 295235000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 631935 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_064555.2(pre=R,post=D) AAQLVDK 602 2 10677 10685 91 4131850000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 644999 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_057582.2(pre=Y,post=G) VLADAIDK 652 2 14885 14899 72 410754000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F12.raw CPTAC_LIHC_Proteome 20171001 20230918 682229 113.HCC.2 113 LIHC 128N male 51 HCC 2 1 0.1-0.3 4 8 0 0 1 1 1 1 12 11 37 43 52 5 NP_996776.2(pre=M,post=G) KAEATVIPSRCAR 640 3 3599 3601 44 22994300
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F12.raw CPTAC_LIHC_Proteome 20171001 20230918 682231 127.HCC.3 128 LIHC 131C male 65 HCC 3 1 0.3 1 4 0 0 1 1 1 1 12 11 38 35 40 343 XXX_NP_002964.3(pre=K,post=N) AESSPTVAR 383 3 3599 3604 20 49089100
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F11.raw CPTAC_LIHC_Proteome 20171001 20230918 650815 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_001098539.1(pre=K,post=E) ELMWNFR 621 2 16629 16633 28 452020000
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F12.raw CPTAC_LIHC_Proteome 20171001 20230918 682625 112.HCC.2 111 LIHC 127C male 69 HCC 2 1 0.1-0.2 1 4 0 0 1 1 1 1 13 15 40 39 25 27 NP_000769.2(pre=F,post=N) SHQGSIQVDR 678 2 4175 4184 62 25567600
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F12.raw CPTAC_LIHC_Proteome 20171001 20230918 683577 125.HCC.3 125 LIHC 130N male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 XXX_NP_997198.2(pre=R,post=V) QHLRAAR 361 3 5663 5675 53 10930400
HBV-Related_Hepatocellular_Carcinoma-Proteome-11 20171001_HF_ZHW_total_liver01_F12.raw CPTAC_LIHC_Proteome 20171001 20230918 684382 125.HCC.3 126 LIHC 130C male 62 HCC 3 1 0.5-0.8 1 9 0 0 1 1 1 0 12 13 42 74 105 839 NP_001186220.1(pre=K,post=W) GGNIGAK 538 2 6863 6866 85 43717300000
연락처 및 데이터 관리
판매제공처 홈페이지 판매담당자 연락처 이메일
www.cellkey.co.kr 셀키 0507-1387-0260 sylee@cellkey.co.kr
제약 및 취소환불 규정
제약 및 취소/환불 규정 안내
데이터 상품은 디지털화된 상품의 특성상 반품, 취소, 환불 되지 않으나 데이터의 심각한 오류, 상이한 데이터에 한하여 구매자가 요구하는 경우 환불을 진행할 수 있습니다.
상품 Q&A

※ 본인의 글만 수정이 가능하며, 타인의 글에 댓글을 남길 수 없습니다.
※ 댓글이 달린 글은 수정과 삭제가 불가능합니다.

등록된 글이 없습니다.